Dementia occurs when proteins in the brain misfold and accumulate, killing neurons and severing the connections between them. This process typically begins 10 to 20 years before any noticeable symptoms appear, silently damaging brain tissue during what researchers call the preclinical stage. The specific proteins involved and the brain regions they target differ depending on the type of dementia, but the end result is the same: progressive loss of memory, thinking, and eventually the ability to function independently.
An estimated 57 million people worldwide were living with dementia in 2019, and that number is projected to reach 153 million by 2050. Understanding what happens inside the brain helps explain why the disease unfolds the way it does, and why certain risk factors matter so much.
Protein Buildup: Where It All Starts
The most common form of dementia, Alzheimer’s disease, involves two rogue proteins. The first is amyloid-beta, a fragment created when enzymes break down a larger protein on the surface of neurons. In a healthy brain, amyloid-beta is produced and cleared away in balance. In Alzheimer’s, that clearance system fails. The fragments pile up between neurons, clumping into sticky deposits called plaques.
The second protein is tau. Tau normally acts like scaffolding inside neurons, helping them maintain their shape and transport nutrients. In Alzheimer’s, tau becomes chemically altered through a process called hyperphosphorylation. The altered tau detaches from the neuron’s internal structure and tangles together into dense knots called neurofibrillary tangles. Once tangles form inside a neuron, the cell can no longer function and eventually dies.
These two processes, plaques outside cells and tangles inside them, work together to destroy brain tissue. Plaques appear to trigger inflammation and disrupt signaling between neurons, while tangles collapse the cell from within. The combination is what makes Alzheimer’s so destructive.
How Neurons Lose Their Ability to Communicate
Even before neurons die outright, dementia disrupts the chemical messaging system they rely on. Neurons communicate by releasing molecules called neurotransmitters across tiny gaps between cells. One of the most important for memory and learning is acetylcholine. As Alzheimer’s progresses, the neurons that produce acetylcholine are among the first to degenerate, and the receptors that detect it decline sharply in the brain’s memory and thinking centers.
This matters because acetylcholine doesn’t just carry signals on its own. It also helps regulate the release of glutamate, the brain’s primary excitatory neurotransmitter. Glutamate is essential for strengthening or weakening connections between neurons, which is the physical basis of learning. When the acetylcholine system breaks down, glutamate signaling goes haywire too, creating a cascade effect that undermines the brain’s ability to form and retrieve memories.
The Brain Shrinks in a Predictable Pattern
Dementia doesn’t damage the brain randomly. In Alzheimer’s, the destruction follows a remarkably consistent path. It starts in the medial temporal lobe, specifically a structure called the hippocampus, which is the brain’s hub for forming new memories. This is why forgetting recent events is almost always the earliest symptom.
From there, the damage gradually spreads outward into the broader cortex, the folded outer layer responsible for language, reasoning, spatial awareness, and personality. As more regions are affected, symptoms expand beyond memory loss to include confusion, difficulty speaking, trouble navigating familiar places, and changes in behavior. Brain imaging studies show that people with mild cognitive impairment already have measurable shrinkage in the hippocampus, while those with diagnosed Alzheimer’s show more widespread atrophy across the cortex.
Not All Dementia Follows the Same Path
Alzheimer’s accounts for roughly 60 to 70 percent of dementia cases, but other types involve different mechanisms.
Vascular dementia is the second most common form. It happens when blood flow to the brain is reduced or blocked, depriving neurons of oxygen and nutrients. This can result from a major stroke, a series of smaller strokes that may go unnoticed, or chronic damage to the brain’s small blood vessels over years of high blood pressure or diabetes. The symptoms depend on which part of the brain loses blood supply, so vascular dementia can look quite different from person to person. Some people experience sudden declines after a stroke, while others deteriorate in a slow, stepwise pattern.
Lewy body dementia involves a different protein entirely: alpha-synuclein. In a healthy brain, this protein plays a role in neuron signaling. But it can misfold into an abnormal shape rich in a structure called beta-sheets, which makes it toxic. These misfolded proteins clump together inside neurons, forming deposits known as Lewy bodies. The result is a distinctive combination of cognitive decline, visual hallucinations, and movement problems similar to Parkinson’s disease. In animal studies, the spread of misfolded alpha-synuclein through the brain causes progressive motor deterioration, starting with reduced movement and advancing to paralysis.
Frontotemporal dementia targets the frontal and temporal lobes, which govern personality, behavior, and language. It tends to strike earlier in life, often between ages 45 and 65, and the initial symptoms are more likely to involve personality changes or difficulty with speech than memory loss.
Why Some Brains Are More Vulnerable
Genetics play a significant role in determining who develops dementia. The strongest known genetic risk factor for Alzheimer’s is a gene variant called APOE4. Everyone inherits two copies of the APOE gene, one from each parent. Carrying one copy of the APOE4 variant increases risk substantially. Carrying two copies, which occurs in about 2 to 3 percent of the population, gives a person roughly a 60 percent chance of developing Alzheimer’s dementia by age 85, according to research from the National Institutes of Health. A 2024 study went further, arguing that having two APOE4 copies represents a distinct genetic form of the disease rather than simply a risk factor.
Rare mutations in other genes can cause Alzheimer’s to develop much earlier, sometimes in a person’s 30s or 40s. These familial forms account for a small fraction of cases but have been crucial for understanding how the disease works, because they demonstrate that amyloid-beta buildup alone can trigger the full cascade of Alzheimer’s pathology.
The Long Silent Phase Before Symptoms
One of the most striking aspects of dementia is how long the brain can sustain damage before anything seems wrong. Research shows that Alzheimer’s pathology develops for years or even decades before clinical symptoms appear. During this preclinical stage, plaques and tangles are accumulating, neurons are beginning to die, and certain brain regions are already shrinking, but the brain compensates by rerouting signals and relying on redundant pathways.
This long runway has two important implications. First, it means that by the time someone notices memory problems, the disease is already well established. Second, it means there is a substantial window during which interventions could theoretically slow or prevent progression, if people at risk can be identified early enough.
Risk Factors You Can Actually Change
A landmark 2024 report from The Lancet Commission on dementia identified 14 modifiable risk factors that collectively account for a significant share of dementia cases worldwide. The list includes hearing loss, high blood pressure, smoking, obesity, depression, physical inactivity, diabetes, excessive alcohol consumption, traumatic brain injury, air pollution, social isolation, and less education. The 2024 update added two new factors backed by strong evidence: untreated vision loss and high LDL cholesterol.
None of these factors guarantee dementia on their own. But each one contributes to the kind of brain damage, whether vascular, inflammatory, or related to reduced neural stimulation, that makes the brain less resilient as it ages. Addressing them doesn’t eliminate risk, especially for people with strong genetic predispositions. But the evidence is now robust that managing these factors across a lifetime meaningfully reduces the odds of developing dementia.
Physical inactivity and high blood pressure are particularly important because they contribute to both Alzheimer’s and vascular dementia. Exercise improves blood flow to the brain, reduces inflammation, and promotes the growth of new connections between neurons. Managing blood pressure protects the small vessels that keep brain tissue alive. Social engagement and treating sensory loss like hearing or vision problems help maintain the cognitive stimulation that keeps neural networks active and resilient.